These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 30643940)

  • 1. Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer.
    Wang L; Dong T; Xin B; Xu C; Guo M; Zhang H; Feng D; Wang X; Yu J
    Eur Radiol; 2019 Jun; 29(6):2958-2967. PubMed ID: 30643940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis prediction of extremity and trunk wall soft-tissue sarcomas treated with surgical resection with radiomic analysis based on random survival forest.
    Yang Y; Ma X; Wang Y; Ding X
    Updates Surg; 2022 Feb; 74(1):355-365. PubMed ID: 34003477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients.
    Yang L; Yang J; Zhou X; Huang L; Zhao W; Wang T; Zhuang J; Tian J
    Eur Radiol; 2019 May; 29(5):2196-2206. PubMed ID: 30523451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
    Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
    Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers.
    Xie D; Allen MS; Marks R; Jiang G; Sun Z; Nichols F; Zhang M; Chen C; Aubry MC; Jatoi A; Garces YI; Mansfield A; Wigle D; Molina J; Deschamps C; Yang P
    Eur J Cardiothorac Surg; 2018 Jun; 53(6):1214-1222. PubMed ID: 29293957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT-based radiomics for predicting brain metastases as the first failure in patients with curatively resected locally advanced non-small cell lung cancer.
    Sun F; Chen Y; Chen X; Sun X; Xing L
    Eur J Radiol; 2021 Jan; 134():109411. PubMed ID: 33246270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomograms integrating CT radiomic and deep learning signatures to predict overall survival and progression-free survival in NSCLC patients treated with chemotherapy.
    Chang R; Qi S; Wu Y; Yue Y; Zhang X; Qian W
    Cancer Imaging; 2023 Oct; 23(1):101. PubMed ID: 37867196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction and verification of survival in patients with non-small-cell lung cancer based on an integrated radiomics nomogram.
    Li R; Peng H; Xue T; Li J; Ge Y; Wang G; Feng F
    Clin Radiol; 2022 Mar; 77(3):e222-e230. PubMed ID: 34974912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer.
    de Jong EEC; van Elmpt W; Rizzo S; Colarieti A; Spitaleri G; Leijenaar RTH; Jochems A; Hendriks LEL; Troost EGC; Reymen B; Dingemans AC; Lambin P
    Lung Cancer; 2018 Oct; 124():6-11. PubMed ID: 30268481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
    Wang X; Zhao X; Li Q; Xia W; Peng Z; Zhang R; Li Q; Jian J; Wang W; Tang Y; Liu S; Gao X
    Eur Radiol; 2019 Nov; 29(11):6049-6058. PubMed ID: 30887209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The advanced lung cancer inflammation index (ALI) predicted the postoperative survival rate of patients with non-small cell lung cancer and the construction of a nomogram model.
    Ma S; Li Z; Wang L
    World J Surg Oncol; 2024 Jun; 22(1):158. PubMed ID: 38877553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
    Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
    Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of radiomic features, clinic characteristics, and serum tumor biomarkers to predict the possibility of the micropapillary/solid component of lung adenocarcinoma.
    Xing X; Li L; Sun M; Zhu X; Feng Y
    Ther Adv Respir Dis; 2024; 18():17534666241249168. PubMed ID: 38757628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship and prognostic significance between preoperative serum albumin to globulin ratio and CT features of non-small cell lung cancer.
    Guo X; Shao J; Zhai B; Zou Q; Yan J; Gu H; Wang G
    Eur J Radiol; 2020 Jul; 128():109039. PubMed ID: 32417713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Radiomics Nomogram Based on
    Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
    Front Oncol; 2020; 10():1042. PubMed ID: 32766134
    [No Abstract]   [Full Text] [Related]  

  • 16. Machine learning model to preoperatively predict T2/T3 staging of laryngeal and hypopharyngeal cancer based on the CT radiomic signature.
    Liu Q; Liu S; Mao Y; Kang X; Yu M; Chen G
    Eur Radiol; 2024 Aug; 34(8):5349-5359. PubMed ID: 38206403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
    Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
    Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors.
    Zhu C; Ding J; Wang S; Qiu Q; Ji Y; Wang L
    Thorac Cancer; 2021 Dec; 12(23):3110-3120. PubMed ID: 34647417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
    Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
    Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas.
    Das SK; Fang KW; Xu L; Li B; Zhang X; Yang HF
    Sci Rep; 2021 May; 11(1):10829. PubMed ID: 34031529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.